Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension

Journal of Hypertension

Volumn 18, Issue 7, 2000, Pages 945-953

  Fu, Michael L X ^a   Herlitz, Hans ^b   Schulze, Wolfgang ^c   Wallukat, Gerd ^c   Micke, Patrick ^d   Eftekhari, Pierre ^e   Sjögren, Klas Göran ^a   Hjalmarson, Åke ^a   Müller Esterl, Werner ^d   Hoebeke, Johan ^e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Angiotensin II receptor; Autoantibodies; Enzyme immunoassay; Epitope; Malignant hypertension; Peptide

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; AUTOANTIBODY; BRADYKININ RECEPTOR; RECEPTOR ANTIBODY;

ADULT; ARTICLE; CELL CULTURE; CHO CELL; CHRONOTROPISM; CLINICAL ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME IMMUNOASSAY; FEMALE; HEART MUSCLE CELL; HUMAN; HYPERTENSION; MALE; MALIGNANT HYPERTENSION; PRIORITY JOURNAL; RENOVASCULAR DISEASE;

EID: 0033911364     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018070-00017     Document Type: Article

References (26)

1. 1 Gudbrandsson T, Hansson L, Herlitz H, Lindholm L, Nilsson L-Ȧ. Immunological changes in patients with previous malignant essential hypertension. Lancet 1981; i:406-408.
2. 2 Hilme E, Herlitz H, Söderström T, Hansson L. Increased secretion of immunoglobulins in malignant hypertension. J Hypertens 1989; 7:91-95.
3. 3 Wilson JD, Bullock JY, Booth RJ. Autoantibodies in essential hypertension [letter]. Lancet 1978; ii:996.
4. 4 Kristensen BO, Andersen PL. Autoantibodies in untreated and treated essential hypertension. Acta Med Scand 1978; 203:55-59.
5. 1-adrenergic receptors in patients with malignant hypertension. Lancet 1994; 344:1660-1663.
6. 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 1997; 29:678-682.
7. 7 Fu LXM, Magnusson Y, Bergh C-H, Liljeqvist J-Ȧ, Waagstein F, Hjalmarson Ȧ, et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993; 91:1964-1968.
8. 8 Fu LXM, Hoebeke J, Matsui S, Matoba M, Magnusson Y, Hedner T, et al. Autoantibodies against cardiac G protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol 1994; 72:15-20.
9. 9 Elies R, Ferrari I, Wallukat G, Lebesgue D, Chiale P, Elizari M, et al. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J Immunol 1996; 157:4203-4211.
10. 10 Timmermans PB, Wong PC, Chiu AT, Herbin WF, Benfield B, Carini DJ, et al. Angiotensin II receptor agonists and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205-227.
11. 11 Wong PC, Hart SD, Zaspel A, Chiu AT, Smith RD, Timmermans PB. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: Dup 753 (AII-1) and PD 123177 (AII-2). J Pharmacol Exp Ther 1990; 255:584-592.
12. 12 Dzau VJ, Sasamora H, Hein L. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. J Hypertens 1993; II(Suppl 3):S13-S18.
13. 13 Bergsma DJ, Ellis C, Kumar C, Nuthulaganti P, Kersten H, Elshourbagy N, et al. Cloning and characterization of a human angiotensin II type 1 receptor. Biochem Biophys Res Commun 1992; 183:989-995.
14. 14 Martin MM, Su B, Elton TS. Molecular cloning of the human angiotensin II type II receptor cDNA. Biochem Biophy Res Commun 1994, 205:645-651.
15. 1 angiotensin receptors. Am J Hypertens 1992; 5:236s-242s.
16. 2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies. J Biol Chem 1996; 271:1748-1755.
17. 17 World Health Organization: Report of a WHO Expert Committee. Arterial hypertension, WHO Tech Rep Ser No 628 (1978)
18. 1-adrenergic receptor. Clin Exp Immunol 1994; 97:146-151.
19. 19 Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun 1992; 184:260-268.
20. 1a receptor : a useful tool for structure-function relationship analysis. Biochem Biophys Res Commun 1994; 198:1347-1354.
21. 1) in the heart with anti-peptide antibodies, showing a positive chronotropic effect. Receptors and Channels 1998; 6:99-111.
22. 22 Lowry DH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-275.
23. 23 Wallukat G, Wollenberger A. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic β-adrenergic function in cultured rat heart myocytes. Biomed Biochim Acta 1987; 78:634-639.
24. 24 Hoebeke J. La seconde boucle extracellutaire des récepteurs couplés aux protéines G: une cible préférentielle pour les autoanticorps fonctionnels. Médecine/Sciences 1995; 12:1661-1667.
25. 25 Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, et al. Patients with preclampsia develop agonistic autoantibodies against the angiotensin AT(1) receptor. J Clin Invest 1999, 103:945-952.
26. 26 Fu LXM, Schulze W, Wallukat G, Hjalmarson Ȧ, Hoebeke J. Functional epitope analysis of the second extracellular loop of the human heart muscarinic acetylcholine receptor. J Mol Cell Cardiol 1995; 27:427-436.